Related Experiment Videos
[Interstitial pneumonia due to Chlamydia trachomatis in infants. Three cases (author's transl)]
Insights
Chlamydia trachomatis lung infection in infants presents with persistent cough and difficulty breathing, often without fever. Early diagnosis and erythromycin treatment are key for managing this common early-life respiratory illness.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neonatology
Background:
- Chlamydia trachomatis is a common sexually transmitted bacterium.
- Neonatal infections can lead to significant morbidity.
Observation:
- Infants presented with early-onset (13-15 days) respiratory symptoms, including cough and dyspnea.
- Symptoms persisted in 2/3 of cases, with absence of infectious signs and fever.
- Radiological findings suggested interstitial pneumonia with blood eosinophilia and elevated immunoglobulin levels.
Findings:
- Diagnosis was confirmed by serological tests (titer > 1/32th) in infants and parents.
- Erythromycin treatment proved effective in managing the condition.
- Intranatal transmission is the likely route of infection.
Implications:
- Chlamydia trachomatis lung infection should be considered in neonates with unexplained respiratory distress.
- This condition may account for a significant proportion of early-life respiratory infections in France and the USA.
- Timely diagnosis and treatment are crucial to prevent prolonged illness and potential complications.
Abstract:
The early onset of the disease (between the 13th and 15th days of life) and its long duration in 2 out of 3 cases, the absence of infectious symptoms and the efficacy of erythromycin treatment were characteristic features. The diagnosis was confirmed by positive (greater than 1/32th) serological tests in both infants and parents. Chlamydia trachomatis lung infection should be suspected in infants presenting, during the first weeks of life, with cough and dyspnoea unaccompanied by fever, radiological evidence of interstitial pneumonia, blood eosinophilia and raised immunoglobulin levels. The disease results from intranatal contamination and might represent, in France as in the U.S.A., an important percentage of respiratory infections occurring during the early months of life.